Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells

Figure 1

Schematic representations of Gemcitabine encapsulation into two biodegradable nanovectors. (A) PLGem is defined as Gemcitabine encapsulated in poly(lactic-co-glycolic) acid (PLGA) nanoparticles having a molecular weight of around 4.2 kDa by emulsion-evaporation technique. Magnification shows the predicted arrangement of Gemcitabine. (B) GemPo refers to Gemcitabine encapsulated in phosphatidylcholine-based liposomes using the lipid film hydration technique. Magnification shows the lipid bilayer.

Back to article page